Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2010
09/07/2010US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/07/2010CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/02/2010WO2010099458A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
09/02/2010WO2010098475A1 Agent for prevention and treatment of eating disorders
09/02/2010WO2010098417A1 Magnesium oxide fine granules
09/02/2010WO2010098145A1 Oxyindole derivatives with motilin receptor agonistic activity
09/02/2010WO2010097816A1 Flavanoid compounds and process for preparation thereof
09/02/2010WO2010097583A1 Esomeprazole potassium polymorph and its preparation
09/02/2010WO2010097419A1 Conditionally replicating adenovirus effective in the treatment of tumors
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010079504A3 Stable r (+) -lansoprazole amine salt and a process for preparing the same
09/02/2010WO2009027614A3 Method for splitting omeprazole salts
09/02/2010US20100222591 New Compounds
09/02/2010US20100222432 Synthetic Carbon Nanotubes
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100222393 Muscarinic receptor antagonists
09/02/2010US20100222391 Benzimidazole compound crystal
09/02/2010US20100222390 Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222377 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
09/02/2010US20100222372 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
09/02/2010US20100222365 Substituted triazole deriviatives as oxytocin antagonists
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
09/02/2010US20100222324 Substituted Indole Compounds
09/02/2010US20100222315 Patient populations and treatment methods
09/02/2010US20100222300 A2B Adenosine Receptor Antagonists
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222291 Medicinal forms of phospholipid preparations and methods for their preparation
09/02/2010US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities
09/02/2010US20100222280 PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222271 Formulation to Improve Gastrointestinal Function
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
09/02/2010US20100221336 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
09/02/2010US20100221330 Buoyant formulations of betaine
09/02/2010US20100221329 Formulations of guanylate cyclase c agonists and methods of use
09/02/2010US20100221325 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers
09/02/2010US20100221270 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
09/02/2010US20100221227 Novel method of treating disease
09/02/2010US20100221217 Therapeutic composition
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753316A1 Magnesium oxide granules
09/02/2010CA2751220A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
09/02/2010CA2750699A1 Oxyindole derivatives with motilin receptor agonistic activity
09/01/2010EP2223927A2 Cyclic phosphonic acid based prodrugs of PMEA and its analogues
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2222320A2 Novel milk thistle extract, method for the production, and use
09/01/2010EP2222291A2 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
09/01/2010EP2222289A1 Treatment of oral pharyngeal dysphagia
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1874766B1 Crystalline form of a quinolinone-carboxamide compound
09/01/2010EP1669367B1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
09/01/2010EP1607394B1 Water-soluble thalidomine derivatives
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level
09/01/2010CN1895453B Juyi oral preparation
09/01/2010CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/01/2010CN101820883A Method for inducing hepatocyte proliferation and uses thereof
09/01/2010CN101820882A Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
09/01/2010CN101820880A Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
09/01/2010CN101818152A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
09/01/2010CN101817932A Polyamido-amine dendrimers -modified macroporous crosslinked chitosan microsphere and preparation method thereof
09/01/2010CN101817742A Crystal form X of sofalcone, preparation method and use thereof
09/01/2010CN101817741A Crystal form IX of sofalcone, preparation method and use thereof
09/01/2010CN101816790A Spray for treating radioactive xerostomia and preparation method thereof
09/01/2010CN101816773A Method for measuring content of superfine powder preparation in five retentions powder
09/01/2010CN101816765A Toxin-expelling and skin-nourishing pill
09/01/2010CN101816764A Chinese medicament granule preparation for warming kidney, soothing liver, activating spleen and stomach, purging bowels, eliminating stubborn stool and releasing toxin
09/01/2010CN101816761A Chinese medicinal composition for treating liver cancer and preparation method thereof
09/01/2010CN101816748A Chinese medicament for preventing and treating dog diarrhea and preparation method thereof
09/01/2010CN101816745A Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof
09/01/2010CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound
09/01/2010CN101816739A Chinese medicinal composition and preparation method thereof
09/01/2010CN101816738A Anti-fatigue nutrient health-care wine for improving male sexual function and preparation method thereof
09/01/2010CN101816732A Chinese medicinal decoction for treating toothache
09/01/2010CN101816730A Chinese medicinal composition for treating fire tooth and decayed tooth
09/01/2010CN101816726A Effervescent traditional Chinese medicine composition having intense heat-purging and detoxicating function and preparation method thereof
09/01/2010CN101816725A Effervescent traditional Chinese medicine composition having intestine-astringing and dysentery-relieving function and preparation method thereof
09/01/2010CN101816724A Effervescent traditional Chinese medicine composition having dampness removing and diarrhea-relieving function and preparation method thereof
09/01/2010CN101816723A Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof
09/01/2010CN101816711A Effervescent Chinese medicinal composition for curing avian dysentery and preparation method thereof
09/01/2010CN101816710A Chinese medicinal composition for treating gall-stone
09/01/2010CN101816707A Lindera reflexa Hemsl ethylacetate part extract and application thereof
09/01/2010CN101816701A Process for preparing kudzu root extract instant grains